End-stage renal disease trials recruiting in Massachusetts

All End-stage renal disease trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
  NCT05931276 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
  NCT04399941 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Massachusetts: Boston
• Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
  NCT06190717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female) · Massachusetts: Boston
• Partners Calciphylaxis Biobank
  NCT03032835 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
  NCT06516653 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Massachusetts: Boston
• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
  NCT04634916 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Springfield, West Springfield, Worcester
• SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
  NCT06001827 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
  NCT04580420 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · Massachusetts: Boston
• Safety and Efficacy of Empagliflozin in Hemodialysis
  NCT05786443 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston